Clínic Barcelona

Temporarily replacing tacrolimus with prednisone enables safe, effective short-term treatment using ritonavir-boosted antivirals in solid organ transplant recipients with COVID-19

Clínic Barcelona-IDIBAPS researchers have demonstrated that replacing the immunosuppressant drug tacrolimus with prednisone prevents the appearance of toxicity due to interaction with ritonavir.

The Clínic Barcelona-IDIBAPS researchers responsible for the study.

Related contents
Keep reading about:

Related news